Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

4 Mar 2015 07:00

RNS Number : 4606G
Carillion PLC
04 March 2015
 



 

 

 

 

 

Annual results for the year ended 31 December 2014

Earnings in line with expectations

 

2014

2013

Change

Revenue

£4.1bn

£4.1bn

-

Underlying profit from operations(1)

£216.9m

£214.3m

+1%

Underlying operating margin(1)

5.6%

5.6%

-

Underlying profit before taxation(1)

£172.9m

£174.7m

-1%

Underlying earnings per share(1)

33.7p

34.7p

-3%

Profit before taxation

£142.6m

£110.6m

+29%

Basic earnings per share

28.0p

23.3p

+20%

Proposed full-year dividend per share

17.75p

17.50p

+1%

Net borrowing

£177.3m

£215.2m

+18%

Underlying profit from operations cash conversion(1)

119%

75%

n/a

 

· Financial performance reflects selective approach to choosing contracts in challenging markets

- Revenue similar to that in 2013, notwithstanding foreign exchange headwinds

- Underlying profit from operations(1) increased slightly after improved margin performances in support services and Middle East construction services, with overall Group margin maintained at 5.6%

- Underlying profit before taxation(1) and underlying earnings per share(1) marginally reduced, reflecting the planned reduction in the sale of equity investments in Public Private Partnership projects

- Reported profit before taxation and basic earnings per share both increased substantially, due to lower non-recurring operating items

 

· Net borrowing reduced in line with expectations

- Net borrowing reduced to £177.3 million (2013: £215.2 million), despite investing £38.5 million in business acquisitions

- Strong cash performance with underlying cash flow from operations(1) representing 119% of underlying profit from operations(1) (2013: 75%)

- £1.3 billion of committed funding and a strong balance sheet to support strategy for growth over the medium term

 

· Strong work-winning performance

- £5.1 billion of new orders and probable orders in the year (2013: £4.9 billion)

- High-quality order book plus probable orders totalling £18.6 billion (2013: £18.0 billion)

- Record revenue visibility(2) of 85% for 2015 (2013: 81% for 2014)

- Framework contracts worth up to £2.0 billion, which are not included in the order book or probable orders

- Pipeline of contract opportunities increased to £39.2 billion (2013: £37.5 billion)

 

· Proposed full-year dividend increased by 1% to 17.75p (2013: 17.50p)

 

(1)

The underlying results stated above are based on the definitions included in the key financial figures on page 3.

(2)

Based on expected revenue and secure and probable orders, which exclude variable work, frameworks and re-bids.

 

 

 

 

Carillion Chairman, Philip Green, commented

 

"In 2014, our markets remained challenging and we continued to be very selective in choosing the contracts for which we bid in order to maintain margin discipline, which continues to be a key element of our strategy. Looking forward, we expect the steady improvement in our markets that began in 2014 to continue in 2015, subject to a sustained macro-economic recovery. We have also continued to strengthen the Group's position in growth markets, notably in support services through a further bolt-on acquisition in Canada. Therefore, with strong cash flow, a high-quality order book, record revenue visibility and a growing pipeline of contract opportunities, we continue to believe the Group is well-positioned to make progress over the medium term." 

 

There will be a presentation for analysts and investors today at 9.00am. A telephone dial in facility +44 (0)1296 480 100 - Access Code: 284405# will be available for analysts and investors who are unable to attend the presentation. The presentation can be viewed on Carillion's website at www.carillionplc.com/investors/investors_presentations.asp. A replay facility is also available following the call on +44 (0)207 136 9233 - Access Code: 61737143.

 

For further information contact:

Richard Adam, Group Finance Director

John Denning, Group Corporate Affairs Director

Finsbury - James Murgatroyd and Gordon Simpson

tel: +44 (0) 1902 422431

tel: +44 (0) 1902 422431

tel: +44 (0) 20 7251 3801

 

4 March 2015

 

Notes to Editors:

Carillion is a leading integrated support services company with a substantial portfolio of Public Private Partnership projects and extensive construction capabilities. The Group had annual revenue in 2014 of some £4.1 billion, employs around 42,000 people and operates across the UK, in the Middle East and Canada. 

The Group has four business segments:

 

Support services - this includes facilities management, facilities services, energy services, utility services, road maintenance, rail services and consultancy businesses in the UK, Canada and the Middle East.

 

Public Private Partnership (PPP) projects - this includes investing activities in PPP projects for Government buildings and infrastructure, mainly in the Defence, Health, Education, Transport and Secure accommodation sectors.

 

Middle East construction services - this includes building and civil engineering activities in the Middle East.

 

Construction services(excluding the Middle East) - this includes building, civil engineering and developments activities in the UK and construction activities in Canada.

 

This and other Carillion news releases can be found at www.carillionplc.com

 

Cautionary statement

This announcement may contain indications of likely future developments and other forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. These and other factors could adversely affect the Group's results, strategy and prospects. Forward-looking statements involve risks, uncertainties and assumptions. They relate to events and/or depend on circumstances in the future which could cause actual results and outcomes to differ materially from those currently anticipated. No obligation is assumed to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Click on, or paste the following link into your web browser, to view the associated PDF of the Preliminary Results Announcement:http://www.rns-pdf.londonstockexchange.com/rns/4606G_-2015-3-3.pdf

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR DDGDXBDGBGUX
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.